Anne E. White - Feb 1, 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & Pres, Lilly Neuroscience
Signature
/s/ Jonathan Groff for Anne E. White, pursuant to authorization on file
Stock symbol
LLY
Transactions as of
Feb 1, 2025
Transactions value $
-$1,181,826
Form type
4
Date filed
2/4/2025, 04:27 PM
Previous filing
Feb 14, 2024
Next filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Options Exercise $0 +3.27K +4.99% $0.00 68.8K Feb 1, 2025 Direct
transaction LLY Common Stock Tax liability -$1.18M -1.46K -2.12% $811.08 67.4K Feb 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Options Exercise $0 -3.27K -100% $0.00 0 Feb 1, 2025 Common Stock 3.27K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.